Advanced Filters
noise

transplant-rejection Clinical Trials

A listing of transplant-rejection medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 85 clinical trials
W Weiqiang Tan, M.D.

Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation

The purpose of this study was to explore the accuracy of sentinel skin grafts from the same donor source in diagnosing renal allograft rejection, and to provide new ideas and options for the later clinical diagnosis of renal allograft rejection. Further, try to provide timing guidance for early immunization intervention.

18 - 60 years of age Both Phase N/A
S Sandra Lindstedt Ingemansson, MD, PhD

Exhaled Breath Particles in Lung Transplantation

Lung transplantation (LTx) is the only effective treatment for patients with end stage lung disease. Of the major organs transplanted, survival following LTx is the lowest with a mean of 5 years. Despite improvements, primary graft dysfunction (PGD) remains the leading cause of early mortality and contributes to the development …

16 - 75 years of age Both Phase N/A

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection

Acute rejection after kidney transplantation should ideally be diagnosed prior to immunologic injury in a non-invasive fashion in order to improve long-term graft function. Donor-derived cell-free DNA (ddcfDNA) is a promising method to do so as it is elevated prior to acute rejection and has good predictive performance especially for …

18 - 100 years of age Both Phase N/A
L Lukas K van Vugt, Drs.

Reduced-dose Alemtuzumab for Kidney Transplant Rejection

Prospective, follow-up study of kidney transplant recipients treated with alemtuzumab anti-rejection therapy for severe or glucocorticoid-resistant kidney transplant rejection.

18 - 100 years of age Both Phase N/A
J Jérôme Le Pavec, MD

Quantitative Parameters of HLA-DQ Antibodies in Lung Transplantation

The aim is to compare the quantitative parameters of de novo anti-HLA DQ Donor Specific Antibodies (DSA), determined at the time of their discovery by surface plasmon resonance (SPR), between recipients that developed a Chronic Lung Allograft Dysfunction (CLAD) for the 2 years following DSA apparition and those who did …

18 - 100 years of age Both Phase N/A
J Jan-Stephan Sanders, MD, PhD

Incidence, Course and Outcome of ABMR in Kidney Transplantation

Rationale: Despite improved patient and graft survival in renal transplant recipients, still 20% of the patients reaches end-stage renal disease within 5 years after transplantation. Antibody-mediated rejection (ABMR) is one of the major causes of early graft loss and perhaps even more important of late deterioration of graft function Objective: …

18 - 100 years of age Both Phase N/A
K Kyla Thorn

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs (OPTIMA)

This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene …

- 18 years of age Both Phase N/A

MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients

Overall Research Strategy of this protocol is to refine and validate noninvasive CMR imaging sequences with invasive hemodynamic and pathology results to create a comprehensive, noninvasive, radiation-reduced regimen for pediatric cardiomyopathy and cardiac transplant assessment. We were the first to perform MR-guided cardiac catheterization in US children, and have accumulated …

6 - 100 years of age Both Phase N/A
M Marcello Demetri, Biology

Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation

The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.

18 - 100 years of age Both Phase N/A
S Sang-Il Min, MD

ddcfDNA in Kidney Transplant Recipients

The objective of this study is to predict subclinical Antibody-Mediated Rejection (ABMR) occurrences in de novo DSA-positive recipients maintaining stable renal function after transplantation. This will be achieved through the measurement of donor-derived cell-free DNA. The utility of donor-derived cell-free DNA will be validated based on histological findings using Receiver …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI